Evotec

Evotec is a drug discovery alliance and development partnership rapidly progressing innovative product approaches with pharmaceutical and biotechnology companies, academics, patient advocacy groups, and venture capitalists. Drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licencing of innovative drug candidates, and consulting arrangements.

Evotec, established in 1993 and headquartered in Europe., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Biotechnology, Health Care, Pharmaceutical, Therapeutics, Financial Services, Venture Capital, Finance, Intellectual Property, Education, Consulting. The organization boasts a portfolio of 26 investments, with an average round size of $60.5M and 3 successful exits. Their recent investments include Carrick Therapeutics, ARCH Venture Partners, Google Ventures, University of Cambridge Enterprise, Lightstone Ventures. The highest investment round they participated in was $99.6B. Among their most notable exits are Carrick Therapeutics and ARCH Venture Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.